Related Experiment Video
Updated: Jul 18, 2026
12:24
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
Genomics and complex liver disease: Challenges and opportunities
Brian D Juran1, Konstantinos N Lazaridis
1Division of Gastroenterology and Hepatology, Center for Basic Research in Digestive Diseases, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.
Hepatology (Baltimore, Md.)
|November 30, 2006
Summary
Genomics advances our understanding of genetic susceptibility to complex diseases, particularly liver disease. Future research will integrate genetic and environmental factors for better disease prognosis and treatment.
Area of Science:
- Genomics and Human Disease Genetics
- Complex Liver Disease Pathogenesis
Background:
- Genetic susceptibility is a known factor in human disease.
- Genomics now offers advanced tools to study genetic variations influencing disease susceptibility.
- Deciphering the human genome and haplotype map are crucial advancements.
Purpose of the Study:
- To explore the role of genetic predisposition in complex liver disease.
- To understand the interaction between genetic factors and environmental risk factors.
- To lay the groundwork for future human studies on genotype/phenotype relationships in liver disease.
Main Methods:
- Leveraging advancements in genomics for genetic variation assessment.
- Analyzing the interplay of genetic predisposition and environmental influences.
- Planning for large-scale, well-phenotyped patient studies.
Main Results:
- Current understanding of genetic predisposition in complex liver disease is limited.
- Genomics provides new capabilities to assess and interpret genetic variation.
- The interaction between genetic and environmental factors is key to complex liver disease.
Conclusions:
- Future research requires large, well-phenotyped patient cohorts and robust study designs.
- Collaboration among patients, physicians, and genomics scientists is essential.
- This integrated approach promises significant biological discoveries and improved treatments for complex liver diseases.
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:26Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
02:02Genomics
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...